Nurix

Senior Director, Translational Medicine and Clinical Biomarkers

Nurix$280K — $316K *
Pharmaceuticals & Biotech
11 - 15 years of experience
Job Overview by Ladders

Qualifications

  • Advanced degree (Ph.D. or MD preferred) with 12+ years in the pharmaceutical/biotech industry.
  • Significant experience in clinical-stage drug development and deep translational biomarker expertise in Immunology, Oncology, or Hematology.
  • Demonstrated track record of leading biomarker strategy across multiple programs or indications.
  • Extensive technical proficiency in biomarker platforms like flow cytometry, molecular biology, and proteomics.
  • Proven leadership experience with a focus on team scaling in a fast-growing environment.
  • Experience in clinical study protocol development and interactions with regulatory authorities is highly desirable.
  • Strong strategic judgment with the ability to balance portfolio-level priorities.
  • Executive-level communication skills to influence stakeholders on biomarker strategy.

Responsibilities

  • Own and evolve the clinical biomarker strategy for Nurix's entire oncology and immunology portfolio.
  • Provide scientific interpretation of biomarker data to inform patient and dose-selection decisions.
  • Direct the development of biomarker assay capabilities across the portfolio, ensuring consistent execution.
  • Set strategic direction for novel biomarker technologies, anticipating program needs.
  • Lead cross-functional teams to integrate biomarker data into clinical development plans and regulatory strategy.
  • Influence clinical trial design decisions using biomarker insights.
  • Manage and develop team members, scaling the team as needed.
  • Act as a scientific stakeholder in business development discussions relating to biomarker strategy.

Benefits

  • Collaborative and team-oriented work culture.
  • Focus on solutions and results.
  • Hands-on, resourceful approach encouraged.
  • Diverse viewpoints and open discussions are valued.
Full Job Description
Senior Director, Translational Medicine and Clinical Biomarkers

Own the translational science that decides which patients get treated and how - leading biomarker strategy across Nurix's entire oncology and immunology portfolio. This is a senior, portfolio-level role with direct influence on trial design, dosing decisions, and executive strategy from day one.

The Opportunity
  • Own and evolve the clinical biomarker strategy across Nurix's full clinical portfolio, setting priorities that inform patient stratification, response prediction, and resistance mechanisms for multiple concurrent programs (not a single franchise or indication).
  • Provide scientific interpretation of biomarker data, informed by a strong understanding of cell and tumor biology, molecular biology, inflammation, and immuno-oncology, helping translate those insights into patient-selection, dose-selection, go/no-go, and program-level development decisions.
  • Direct the build-out and governance of biomarker assay capabilities across the portfolio, including assay qualification standards, platform strategy, and vendor/CRO oversight, to ensure consistent, scalable execution across programs rather than one-off, program-specific solutions.
  • Set the strategic direction for evaluation and adoption of novel biomarker technologies and platforms, positioning Nurix's biomarker capabilities ahead of program needs rather than reacting to them.
  • Lead and integrate cross-functional, matrixed teams spanning clinical development, research, regulatory, and external collaborators, ensuring biomarker data is embedded in clinical development plans and regulatory strategy at the portfolio level.
  • Provide senior scientific and strategic input into clinical trial design across programs, influencing go/no-go and dose-selection decisions where biomarker data is a critical input.
  • Directly manage and develop at least one direct report, with responsibility for hiring and scaling the team as pipeline needs grow.
  • Act as a key scientific stakeholder in due diligence, business development, and external partnership discussions where biomarker strategy or capabilities are relevant.
  • Model strong executive presence and sound judgment under ambiguity, translating complex biomarker science for scientific and non-scientific audiences alike, including executive leadership and the Board.

What You'll Bring
  • Advanced degree (Ph.D. or MD strongly preferred) with 12+ years of experience in a relevant scientific area within the pharmaceutical or biotech industry, including significant experience in clinical-stage drug development; deep translational biomarker expertise in Immunology, Oncology, or Hematology strongly preferred.
  • Demonstrated track record of developing and leading biomarker strategy across a clinical portfolio - spanning multiple programs or indications - with direct experience influencing clinical trial design and regulatory submissions.
  • Extensive technical depth across diverse platforms - flow cytometry, molecular biology, proteomics, and tissue-based assays - with the judgment to know when to engage personally versus direct through the team.
  • Proven people leadership experience, with at least one direct report managed to date, and demonstrated ability to scale a team in a fast-growing biotech environment.
  • Extensive experience in the design and authoring of clinical study protocols, informed consent forms (ICFs), laboratory manuals, and investigator meeting materials is required. Proven experience contributing to clinical study reports and supporting interactions with regulatory authorities is highly desirable.
  • Executive-level communication skills, with a demonstrated ability to influence senior leadership, Board members, and external partners on biomarker strategy and its implications for program decisions.
  • Strong strategic and organizational judgment, with experience balancing portfolio-level priorities against individual program needs in a resource-constrained environment.
  • A track record of operating effectively in ambiguity, with the credibility and gravitas to be a trusted senior partner to clinical, research, and executive leadership.

Salary Range: $280,400 - $316,500

The posted range applies to roles based in the San Francisco Bay Area and reflects local market conditions. Where an offer lands within that range depends on the candidate's relevant experience, technical expertise, and how their background aligns with the role's requirements.

Location: Onsite - Brisbane, CA

Fit with Nurix Culture and Values
  • Strong team orientation; highly collaborative
  • Solutions and results-oriented focus
  • Hands-on approach; resourceful and open to diverse points of view

About Nurix

Nurix Therapeutics is a biotechnology company that is focused on the discovery, development, and commercialization of small molecule therapies that modulate the ubiquitin proteasome system (UPS) for the treatment of cancer and other diseases. The company's proprietary drug discovery platform is based on the use of DNA-encoded libraries (DELs) to identify small molecules that selectively bind to E3 ligases, which are key enzymes in the UPS. Nurix's lead drug candidate, NX-2127, is a first-in-class small molecule inhibitor of the CBL-B E3 ligase that is being developed for the treatment of solid tumors and hematological malignancies. The company was founded in 2013 and is headquartered in San Francisco, California.
Learn more about Nurix
Size
135 employees
Market Cap
$486 million
Industry
Net Income
-$43.2 million
Founded
2009
Revenue
$17.8 million
NASDAQ

Similar Jobs

More Jobs at Nurix

More Pharmaceuticals & Biotech Jobs

Find similar Senior Director, Translational Medicine and Clinical Biomarkers jobs: